Knott David M Jr Iovance Biotherapeutics, Inc. Transaction History

Knott David M Jr

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 11, 2022	BUY	$6.38 - $18.33 $12,760 - $36,660	2,000 Added 6.53%	32,614 $360,000
Q1 2022 May 16, 2022	BUY	$12.38 - $19.1 $131,153 - $202,345	10,594 Added 52.92%	30,614 $510,000
Q4 2021 Feb 11, 2022	BUY	$16.55 - $27.63 $331,331 - $553,152	20,020 New	20,020 $382,000

314

241M

3.77M

1.7M

Ticker IOVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 157,800,992
Market Cap $1.35B
Description
Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...

Get notified when there are updates to the investment portfolio of Knott David M Jr, based on Form 13F filings with the SEC.

Stay updated on Knott David M Jr with notifications on news.